Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID-19 severe or critically meta-analysis

COLCHIVID
 
NCT04367168
RCTcolchicineplaceboCOVID-19 severe or criticallyNA
66/60 inconclusive
  • inconclusive 17 % decrease in death or transfer to ICU (PE)
Shi
 
NCT04288102
RCTstem cellsplaceboCOVID-19 severe or criticallysome concern
66/35 inconclusive

    PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
    Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).